Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 2 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Recs

0
Player Avatar pchop123 (76.64) Submitted: 8/2/2012 4:33:42 PM : Underperform Start Price: $17.81 ALNY Score: +5.68

grab your parachute & hold it close

Featured Broker Partners


Advertisement